Gerovital
Gerovital
Gerovital (pronounced: jeh-roh-vi-tal) is a pharmaceutical product that was first developed in Romania by Ana Aslan. It is often associated with anti-aging treatments, particularly those related to improving skin health and vitality.
Etymology
The term 'Gerovital' is derived from the Greek words 'gero' meaning old age and 'vital' meaning necessary for life. It was named so due to its proposed benefits in combating the effects of aging.
Usage
Gerovital is primarily used as an anti-aging treatment. It is believed to have beneficial effects on the skin, helping to reduce wrinkles and improve skin elasticity. It is also used in some cases to treat conditions such as arthritis and depression, although the scientific evidence supporting these uses is limited.
Composition
The main active ingredient in Gerovital is procaine, a local anesthetic. It also contains benzoic acid, potassium metabisulfite, and disodium phosphate.
Controversy
Despite its popularity, Gerovital has been the subject of controversy. The Food and Drug Administration (FDA) in the United States has questioned the efficacy and safety of the product, and it is not approved for sale in the US.
Related Terms
External links
- Medical encyclopedia article on Gerovital
- Wikipedia's article - Gerovital
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski